The rare disease content operations platform.
From AI-assisted research to published, embedded, and maintained content — the complete workflow for organizations that take rare disease seriously.
Built for organizations. Right-sized for your stage.
Whether you run a patient advocacy group or a pharma research team, Workspace scales to fit your workflow.
Patient Advocacy Groups
Pro · $249/mo
Co-branded disease embeds for your website, 5 Workspace editing seats, team management, policy alerts for your states, and weekly intelligence digests.
See PAG FeaturesPharma, CROs & Health Systems
Enterprise · $3,500+/mo
AI research reports, competitive intelligence, white-label workspace, unlimited team seats, SSO, and dedicated API access.
Request a DemoThe analysis your team would spend two weeks on. Kisho does it in 60 seconds.
Generate comprehensive disease landscape reports powered by Kisho AI, grounded in 9 parallel data sources — clinical trials, news, policy, company pipelines, and PubMed research. Fully editable in your Workspace.
- Disease Intelligence Brief — 11-section landscape analysis
- Clinical Trial Landscape — competitive trial analysis with sponsor breakdown
- 9 data sources assembled in parallel (clinical, news, policy, pipeline)
- Fully editable in TipTap — export as PDF with your branding
- REFERENCE BLOCK grounding — every claim sourced, no hallucinations
Phenylketonuria — Disease Intelligence Brief
9 sources · March 2026 · Fully editable
Your AI editor understands rare disease.
Highlight any text in your report — instantly Validate the claim, Simplify for patients, Expand with detail, or Cite with a verified source.
- ValidateCheck any claim against source data — get instant confirmation or correction
- SimplifyRewrite complex medical language for patient audiences
- ExpandAdd clinical detail, trial data, or mechanism of action context
- CiteAttach a verified, named source to any statement
Sickle cell disease affects approximately 100,000 Americans and millions worldwide. Recent therapeutic advances have transformed the treatment landscape.
Exagamglogene autotemcel (Casgevy) is the first CRISPR-based gene therapy approved by the FDA for sickle cell disease, receiving approval in December 2023.
Claim verified.
Source: FDA Orphan Drug Designations Database, accessed March 2026
This landmark approval opened new possibilities for patients with severe genotypes...
Workspace Overview
4
Reports
12
Diseases
8
Embeds
3/5
Team
Recent Reports
Custom branding applied · Co-branded embeds active
Your brand on rare disease intelligence.
Configure your organization's workspace with custom branding, co-branded disease embeds, and role-based team access so everyone works from the same source of truth.
- Custom logo, colors, and co-branding on all disease embeds
- Team seats with role-based access (Pro: 5, Enterprise: unlimited)
- Public organization profile and disease directory listing
- Embed analytics — views, clicks, and reach by disease
- Enterprise: white-label workspace with SSO
Put KISHO intelligence anywhere.
Embed live disease profiles on your website with one line of code. Or build your own tools with the KISHO B2B API — structured disease data, trials, news, and policy via REST endpoints.
- Embeddable disease widgets — live content, always up to date
- B2B REST API with structured disease, trial, and news data
- API keys with usage dashboard and rate limit visibility
- WordPress plugin for no-code embed on WP sites
- Enterprise: custom domain, SLA, and dedicated integration support
<script
src="https://cdn.kishomed.io/embed.js"
data-disease="MONDO:0009861"
data-org="your-org-id"
></script>
"label": "Phenylketonuria",
"activeTrials": 14,
"approvedDrugs": 3,
"policyBills": 7,
...
}
Workspace plans
Pro for growing organizations. Enterprise for teams that need unlimited scale.
| Pro $249/mo | Enterprise $3,500+/mo | |
|---|---|---|
| Workspace seats | 5 | Unlimited |
| Disease claims & embeds | 50 | Unlimited |
| AI Research Reports | ||
| Co-branded embeds | ||
| Policy & news alerts | ||
| B2B API access | ||
| White-label workspace | ||
| SSO + dedicated support |
Ready to build your workspace?
Patient organizations start free and upgrade when ready. Enterprise teams get a dedicated onboarding session.
Free for patient organizations. No credit card required.